Search Results 1441-1450 of 18420 for Immunode

1. A Study Of CTX-712 In Relapsed/Refractory Acute Myeloid Leukemia And Higher Risk Myelodysplastic Syndromes - Mayo Clinic

   ... immunodeficiency virus, or acquired immunodeficiency syndrome related illness. Infections controlled with oral anti-infective agents, including prophylactic ...

2. A Study of OX40L As a Functional Biomarker for Liver Fibrosis - Mayo Clinic

   Subjects diagnosed with the Human Immunodeficiency Virus (HIV), or who have tested positive for HIV, documented by any licensed ELISA assay and confirmed by ...

3. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   History of opportunistic infection or immunodeficiency syndrome. Currently on any chronic systemic (oral or intravenous) anti-infective therapy for chronic ...

4. Execute _Preview Minutes_ on HM00000252

   As a reminder to the lab, eye protection must be worn whenever there is the possibility of a spill or splash. All samples considered biosafety level 2/2+ ...

5. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS - Mayo Clinic

   - Human immunodeficiency virus (HIV) seropositivity, or active hepatitis B or C infection based on testing performed within 28 days of enrollment.

6. Oncology (Medical) - Clinical trials

   Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

7. A Study to assess the Safety of NRL-1 for the Treatment of People with Epilepsy - Mayo Clinic

   Positive blood screen for Human immunodeficiency virus (HIV), Hepatitis B surface antigen (HbSAg), Hepatitis C, or a positive urine screen for alcohol, drugs of ...

8. Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair - Mayo Clinic

   Patients positive for human immunodeficiency virus (HIV) are eligible only if they meet all of the following: A stable regimen of highly active anti ...

9. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

   Patient must not have known human immunodeficiency virus (HIV) unless he/she is on effective anti-retroviral therapy, has had at least one viral load test ...

10. A Study to Assess the Effectiveness of Osimertinib Plus Savolitinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib - Mayo Clinic

    Known serious active infection including, but not limited to, tuberculosis, or human immunodeficiency virus (positive human immunodeficiency virus 1/2 ...